Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Capital Expenditures (2023 - 2025)

Fractyl Health (GUTS) has disclosed Capital Expenditures for 3 consecutive years, with $8000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Capital Expenditures fell 96.24% year-over-year to $8000.0, compared with a TTM value of $787000.0 through Sep 2025, down 43.79%, and an annual FY2024 reading of $1.8 million, up 1839.56% over the prior year.
  • Capital Expenditures was $8000.0 for Q3 2025 at Fractyl Health, down from $98000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $1.1 million in Q1 2024 and bottomed at -$132000.0 in Q4 2023.
  • Average Capital Expenditures over 3 years is $219090.9, with a median of $148000.0 recorded in 2023.
  • The sharpest move saw Capital Expenditures surged 5195.0% in 2024, then crashed 96.24% in 2025.
  • Year by year, Capital Expenditures stood at -$132000.0 in 2023, then skyrocketed by 276.52% to $233000.0 in 2024, then crashed by 96.57% to $8000.0 in 2025.
  • Business Quant data shows Capital Expenditures for GUTS at $8000.0 in Q3 2025, $98000.0 in Q2 2025, and $448000.0 in Q1 2025.